Intrinsic value of Teladoc - TDOC

Previous Close

$30.05

  Intrinsic Value

$0.20

stock screener

  Rating & Target

str. sell

-99%

  Value-price divergence*

-93%

Previous close

$30.05

 
Intrinsic value

$0.20

 
Up/down potential

-99%

 
Rating

str. sell

 
Value-price divergence*

-93%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of TDOC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.6

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  59.74
  59.30
  53.87
  48.98
  44.58
  40.63
  37.06
  33.86
  30.97
  28.37
  26.04
  23.93
  22.04
  20.34
  18.80
  17.42
  16.18
  15.06
  14.06
  13.15
  12.34
  11.60
  10.94
  10.35
  9.81
  9.33
  8.90
  8.51
  8.16
  7.84
  7.56
Revenue, $m
  123
  196
  301
  449
  649
  913
  1,252
  1,676
  2,195
  2,817
  3,551
  4,401
  5,370
  6,463
  7,678
  9,015
  10,474
  12,051
  13,745
  15,553
  17,471
  19,498
  21,632
  23,870
  26,212
  28,658
  31,208
  33,864
  36,626
  39,498
  42,483
Variable operating expenses, $m
 
  248
  372
  545
  780
  1,089
  1,486
  1,983
  2,591
  3,321
  4,181
  5,158
  6,295
  7,575
  8,999
  10,567
  12,277
  14,126
  16,112
  18,230
  20,479
  22,855
  25,356
  27,979
  30,725
  33,592
  36,581
  39,693
  42,931
  46,298
  49,797
Fixed operating expenses, $m
 
  33
  34
  34
  35
  36
  37
  38
  39
  40
  41
  42
  43
  44
  45
  46
  48
  49
  50
  51
  52
  54
  55
  56
  58
  59
  61
  62
  64
  65
  67
Total operating expenses, $m
  194
  281
  406
  579
  815
  1,125
  1,523
  2,021
  2,630
  3,361
  4,222
  5,200
  6,338
  7,619
  9,044
  10,613
  12,325
  14,175
  16,162
  18,281
  20,531
  22,909
  25,411
  28,035
  30,783
  33,651
  36,642
  39,755
  42,995
  46,363
  49,864
Operating income, $m
  -71
  -85
  -104
  -131
  -166
  -212
  -271
  -345
  -436
  -544
  -671
  -800
  -968
  -1,157
  -1,367
  -1,598
  -1,851
  -2,123
  -2,416
  -2,729
  -3,060
  -3,410
  -3,779
  -4,166
  -4,570
  -4,993
  -5,433
  -5,892
  -6,369
  -6,865
  -7,381
EBITDA, $m
  -63
  -64
  -82
  -106
  -139
  -183
  -238
  -307
  -391
  -492
  -610
  -748
  -904
  -1,080
  -1,276
  -1,492
  -1,727
  -1,981
  -2,254
  -2,545
  -2,854
  -3,180
  -3,523
  -3,883
  -4,260
  -4,654
  -5,064
  -5,492
  -5,936
  -6,398
  -6,878
Interest expense (income), $m
  2
  2
  5
  8
  13
  19
  28
  39
  52
  69
  89
  113
  140
  172
  207
  246
  289
  336
  387
  442
  500
  562
  628
  697
  769
  844
  923
  1,006
  1,091
  1,181
  1,273
Earnings before tax, $m
  -74
  -88
  -109
  -139
  -179
  -232
  -299
  -384
  -488
  -613
  -760
  -913
  -1,108
  -1,328
  -1,574
  -1,845
  -2,140
  -2,460
  -2,804
  -3,171
  -3,561
  -3,973
  -4,407
  -4,862
  -5,339
  -5,837
  -6,357
  -6,898
  -7,461
  -8,046
  -8,654
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -74
  -88
  -109
  -139
  -179
  -232
  -299
  -384
  -488
  -613
  -760
  -913
  -1,108
  -1,328
  -1,574
  -1,845
  -2,140
  -2,460
  -2,804
  -3,171
  -3,561
  -3,973
  -4,407
  -4,862
  -5,339
  -5,837
  -6,357
  -6,898
  -7,461
  -8,046
  -8,654

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  66
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  304
  379
  583
  869
  1,256
  1,766
  2,421
  3,241
  4,245
  5,449
  6,868
  8,512
  10,388
  12,500
  14,850
  17,438
  20,259
  23,310
  26,587
  30,083
  33,794
  37,714
  41,841
  46,170
  50,701
  55,432
  60,364
  65,500
  70,844
  76,399
  82,173
Adjusted assets (=assets-cash), $m
  238
  379
  583
  869
  1,256
  1,766
  2,421
  3,241
  4,245
  5,449
  6,868
  8,512
  10,388
  12,500
  14,850
  17,438
  20,259
  23,310
  26,587
  30,083
  33,794
  37,714
  41,841
  46,170
  50,701
  55,432
  60,364
  65,500
  70,844
  76,399
  82,173
Revenue / Adjusted assets
  0.517
  0.517
  0.516
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
  0.517
Average production assets, $m
  27
  43
  66
  99
  143
  201
  275
  369
  483
  620
  781
  968
  1,181
  1,422
  1,689
  1,983
  2,304
  2,651
  3,024
  3,422
  3,844
  4,290
  4,759
  5,251
  5,767
  6,305
  6,866
  7,450
  8,058
  8,690
  9,346
Working capital, $m
  62
  -3
  -5
  -7
  -10
  -15
  -20
  -27
  -35
  -45
  -57
  -70
  -86
  -103
  -123
  -144
  -168
  -193
  -220
  -249
  -280
  -312
  -346
  -382
  -419
  -459
  -499
  -542
  -586
  -632
  -680
Total debt, $m
  44
  84
  145
  230
  345
  497
  693
  937
  1,236
  1,595
  2,018
  2,507
  3,067
  3,696
  4,396
  5,167
  6,008
  6,917
  7,894
  8,936
  10,042
  11,210
  12,440
  13,730
  15,080
  16,490
  17,960
  19,490
  21,082
  22,738
  24,459
Total liabilities, $m
  73
  113
  174
  259
  374
  526
  722
  966
  1,265
  1,624
  2,047
  2,536
  3,096
  3,725
  4,425
  5,196
  6,037
  6,946
  7,923
  8,965
  10,071
  11,239
  12,469
  13,759
  15,109
  16,519
  17,989
  19,519
  21,111
  22,767
  24,488
Total equity, $m
  231
  266
  409
  610
  882
  1,240
  1,700
  2,275
  2,980
  3,825
  4,821
  5,975
  7,292
  8,775
  10,425
  12,241
  14,222
  16,364
  18,664
  21,118
  23,723
  26,476
  29,372
  32,412
  35,592
  38,913
  42,376
  45,981
  49,732
  53,632
  57,685
Total liabilities and equity, $m
  304
  379
  583
  869
  1,256
  1,766
  2,422
  3,241
  4,245
  5,449
  6,868
  8,511
  10,388
  12,500
  14,850
  17,437
  20,259
  23,310
  26,587
  30,083
  33,794
  37,715
  41,841
  46,171
  50,701
  55,432
  60,365
  65,500
  70,843
  76,399
  82,173
Debt-to-equity ratio
  0.190
  0.320
  0.350
  0.380
  0.390
  0.400
  0.410
  0.410
  0.410
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
Adjusted equity ratio
  0.693
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702
  0.702

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -74
  -88
  -109
  -139
  -179
  -232
  -299
  -384
  -488
  -613
  -760
  -913
  -1,108
  -1,328
  -1,574
  -1,845
  -2,140
  -2,460
  -2,804
  -3,171
  -3,561
  -3,973
  -4,407
  -4,862
  -5,339
  -5,837
  -6,357
  -6,898
  -7,461
  -8,046
  -8,654
Depreciation, amort., depletion, $m
  8
  21
  22
  24
  26
  30
  34
  39
  45
  52
  61
  52
  64
  76
  91
  107
  124
  143
  163
  184
  207
  231
  256
  282
  310
  339
  369
  401
  433
  467
  502
Funds from operations, $m
  -56
  -67
  -87
  -115
  -152
  -202
  -266
  -345
  -443
  -561
  -700
  -860
  -1,044
  -1,252
  -1,483
  -1,738
  -2,016
  -2,317
  -2,641
  -2,987
  -3,354
  -3,742
  -4,151
  -4,580
  -5,029
  -5,498
  -5,988
  -6,497
  -7,027
  -7,579
  -8,152
Change in working capital, $m
  -4
  -1
  -2
  -2
  -3
  -4
  -5
  -7
  -8
  -10
  -12
  -14
  -16
  -17
  -19
  -21
  -23
  -25
  -27
  -29
  -31
  -32
  -34
  -36
  -37
  -39
  -41
  -42
  -44
  -46
  -48
Cash from operations, $m
  -52
  -65
  -85
  -112
  -149
  -198
  -260
  -339
  -435
  -551
  -688
  -847
  -1,029
  -1,234
  -1,464
  -1,717
  -1,993
  -2,292
  -2,614
  -2,958
  -3,323
  -3,710
  -4,117
  -4,544
  -4,992
  -5,459
  -5,947
  -6,455
  -6,983
  -7,533
  -8,104
Maintenance CAPEX, $m
  0
  -1
  -2
  -4
  -5
  -8
  -11
  -15
  -20
  -26
  -33
  -42
  -52
  -64
  -76
  -91
  -107
  -124
  -143
  -163
  -184
  -207
  -231
  -256
  -282
  -310
  -339
  -369
  -401
  -433
  -467
New CAPEX, $m
  -3
  -16
  -23
  -32
  -44
  -58
  -74
  -93
  -114
  -137
  -161
  -187
  -213
  -240
  -267
  -294
  -321
  -347
  -373
  -398
  -422
  -446
  -469
  -492
  -515
  -538
  -561
  -584
  -608
  -632
  -657
Cash from investing activities, $m
  26
  -17
  -25
  -36
  -49
  -66
  -85
  -108
  -134
  -163
  -194
  -229
  -265
  -304
  -343
  -385
  -428
  -471
  -516
  -561
  -606
  -653
  -700
  -748
  -797
  -848
  -900
  -953
  -1,009
  -1,065
  -1,124
Free cash flow, $m
  -26
  -83
  -111
  -148
  -198
  -263
  -346
  -447
  -569
  -714
  -883
  -1,076
  -1,294
  -1,538
  -1,807
  -2,102
  -2,420
  -2,763
  -3,129
  -3,518
  -3,929
  -4,362
  -4,817
  -5,293
  -5,789
  -6,307
  -6,847
  -7,408
  -7,992
  -8,598
  -9,228
Issuance/(repayment) of debt, $m
  18
  42
  61
  85
  115
  152
  195
  244
  299
  359
  423
  490
  559
  630
  700
  771
  841
  909
  976
  1,042
  1,106
  1,168
  1,230
  1,290
  1,350
  1,410
  1,470
  1,531
  1,592
  1,656
  1,721
Issuance/(repurchase) of shares, $m
  3
  187
  252
  339
  451
  590
  759
  960
  1,193
  1,458
  1,756
  2,066
  2,425
  2,811
  3,224
  3,661
  4,121
  4,602
  5,104
  5,625
  6,166
  6,725
  7,304
  7,902
  8,520
  9,159
  9,819
  10,503
  11,212
  11,946
  12,707
Cash from financing (excl. dividends), $m  
  21
  229
  313
  424
  566
  742
  954
  1,204
  1,492
  1,817
  2,179
  2,556
  2,984
  3,441
  3,924
  4,432
  4,962
  5,511
  6,080
  6,667
  7,272
  7,893
  8,534
  9,192
  9,870
  10,569
  11,289
  12,034
  12,804
  13,602
  14,428
Total cash flow (excl. dividends), $m
  -5
  146
  203
  276
  368
  478
  608
  757
  923
  1,104
  1,297
  1,480
  1,690
  1,903
  2,117
  2,330
  2,541
  2,748
  2,951
  3,149
  3,342
  3,531
  3,717
  3,899
  4,080
  4,261
  4,442
  4,626
  4,812
  5,003
  5,200
Retained Cash Flow (-), $m
  -52
  -187
  -252
  -339
  -451
  -590
  -759
  -960
  -1,193
  -1,458
  -1,756
  -2,066
  -2,425
  -2,811
  -3,224
  -3,661
  -4,121
  -4,602
  -5,104
  -5,625
  -6,166
  -6,725
  -7,304
  -7,902
  -8,520
  -9,159
  -9,819
  -10,503
  -11,212
  -11,946
  -12,707
Prev. year cash balance distribution, $m
 
  64
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  23
  -50
  -63
  -83
  -111
  -150
  -202
  -270
  -355
  -460
  -586
  -735
  -909
  -1,107
  -1,331
  -1,580
  -1,854
  -2,153
  -2,476
  -2,823
  -3,194
  -3,587
  -4,002
  -4,439
  -4,898
  -5,377
  -5,878
  -6,399
  -6,942
  -7,507
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  22
  -45
  -55
  -68
  -86
  -109
  -137
  -169
  -204
  -241
  -278
  -314
  -346
  -372
  -391
  -401
  -403
  -396
  -381
  -359
  -330
  -298
  -262
  -226
  -191
  -157
  -126
  -99
  -76
  -57
Current shareholders' claim on cash, %
  100
  86.1
  75.8
  67.7
  61.2
  55.9
  51.3
  47.5
  44.2
  41.2
  38.7
  36.4
  34.4
  32.6
  31.0
  29.5
  28.1
  26.9
  25.7
  24.7
  23.7
  22.7
  21.9
  21.1
  20.3
  19.6
  18.9
  18.2
  17.6
  17.0
  16.5

Teladoc, Inc. provides telehealth services to its members and their customers in the United States. Its solution connects consumers with its physicians and behavioral health professionals that treat a range of conditions and cases, including acute diagnoses, such as upper respiratory infection, urinary tract infection, and sinusitis; dermatological conditions; anxiety; and smoking cessation. The company offers its services through mobile devices, the Internet, video, and phone. Teladoc, Inc. was founded in 2002 and is based in Purchase, New York.

FINANCIAL RATIOS  of  Teladoc (TDOC)

Valuation Ratios
P/E Ratio -18.8
Price to Sales 11.3
Price to Book 6
Price to Tangible Book
Price to Cash Flow -26.7
Price to Free Cash Flow -25.2
Growth Rates
Sales Growth Rate 59.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -62.5%
Cap. Spend. - 3 Yr. Gr. Rate 24.6%
Financial Strength
Quick Ratio 33
Current Ratio 0
LT Debt to Equity 18.2%
Total Debt to Equity 19%
Interest Coverage -36
Management Effectiveness
Return On Assets -27%
Ret/ On Assets - 3 Yr. Avg. -29.5%
Return On Total Capital -30.8%
Ret/ On T. Cap. - 3 Yr. Avg. -35%
Return On Equity -36.1%
Return On Equity - 3 Yr. Avg. -44.4%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 74%
Gross Margin - 3 Yr. Avg. 74.7%
EBITDA Margin -52%
EBITDA Margin - 3 Yr. Avg. -50%
Operating Margin -57.7%
Oper. Margin - 3 Yr. Avg. -54.8%
Pre-Tax Margin -60.2%
Pre-Tax Margin - 3 Yr. Avg. -58%
Net Profit Margin -60.2%
Net Profit Margin - 3 Yr. Avg. -58%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

TDOC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the TDOC stock intrinsic value calculation we used $123 million for the last fiscal year's total revenue generated by Teladoc. The default revenue input number comes from 2016 income statement of Teladoc. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our TDOC stock valuation model: a) initial revenue growth rate of 59.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for TDOC is calculated based on our internal credit rating of Teladoc, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Teladoc.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of TDOC stock the variable cost ratio is equal to 132.5%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $32 million in the base year in the intrinsic value calculation for TDOC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.6% for Teladoc.

Corporate tax rate of 27% is the nominal tax rate for Teladoc. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the TDOC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for TDOC are equal to 22%.

Life of production assets of 18.6 years is the average useful life of capital assets used in Teladoc operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for TDOC is equal to -1.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $231 million for Teladoc - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 53.452 million for Teladoc is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Teladoc at the current share price and the inputted number of shares is $1.6 billion.

RELATED COMPANIES Price Int.Val. Rating

COMPANY NEWS

▶ Teladoc to Participate in Upcoming Investor Conferences   [Aug-16-17 08:25AM  GlobeNewswire]
▶ Teladoc reports 2Q loss   [12:25AM  Associated Press]
▶ Teladoc Announces Second Quarter 2017 Results   [Aug-02-17 04:01PM  GlobeNewswire]
▶ Teladoc to Participate in Upcoming Investor Conferences   [Aug-01-17 04:21PM  GlobeNewswire]
▶ 3 Stocks Your Children Will Brag About Someday   [Jul-21-17 06:00AM  Motley Fool]
▶ Teladoc Completes Acquisition of Best Doctors   [Jul-17-17 08:25AM  GlobeNewswire]
▶ 3 of 2017's Fastest Growing Companies   [Jul-12-17 12:06PM  Motley Fool]
▶ Teladoc to Announce Second Quarter 2017 Financial Results   [Jul-11-17 08:25AM  GlobeNewswire]
▶ This Company Is Disrupting Doctor's Offices   [Jul-10-17 01:41PM  Motley Fool]
▶ Parexel, Lennar rise; Teladoc, Chipotle Mexican Grill fall   [Jun-20-17 04:28PM  Associated Press]
▶ 3 Hot Small-Cap Tech Stocks   [12:25PM  Investopedia]
▶ Teladoc acquiring Boston medical consultation firm in $440M deal   [Jun-19-17 10:30PM  American City Business Journals]
▶ Harry Boxer: 4 stocks with strong technical momentum   [Jun-15-17 08:48AM  MarketWatch]
▶ ETFs with exposure to Teladoc, Inc. : June 2, 2017   [Jun-02-17 02:33PM  Capital Cube]
▶ Teladoc to Participate in Upcoming Investor Conferences   [Jun-01-17 08:30AM  GlobeNewswire]
▶ ETFs with exposure to Teladoc, Inc. : May 22, 2017   [May-22-17 02:14PM  Capital Cube]
▶ Teladoc Expands Virtual Care Capabilities in Texas   [May-19-17 11:03AM  GlobeNewswire]
▶ ETFs with exposure to Teladoc, Inc. : May 11, 2017   [May-11-17 05:36PM  Capital Cube]
▶ Teladoc, Inc. Value Analysis (NYSE:TDOC) : May 9, 2017   [May-09-17 05:43PM  Capital Cube]
▶ Why Teladoc, Inc. Stock Soared Tuesday   [01:42PM  Motley Fool]
▶ What Is Digital Health?   [07:04AM  Motley Fool]
▶ Teladoc reports 1Q loss   [May-08-17 04:47PM  Associated Press]
▶ Teladoc Announces First Quarter 2017 Results   [04:01PM  GlobeNewswire]
▶ Teladoc to Announce First Quarter 2017 Financial Results   [Apr-11-17 07:20AM  GlobeNewswire]
▶ 3 Stocks on the Motley Fool Money Radar This Week   [Apr-05-17 04:30PM  Motley Fool]
▶ In Your 40s? 3 Stocks You Might Want to Buy   [Apr-01-17 11:04AM  Motley Fool]
▶ Teladoc Telehealth System Now Live at Jefferson Health   [Mar-30-17 08:35AM  Business Wire]
▶ 3 Stocks With NVIDIA-like Return Potential   [Mar-18-17 08:44AM  Motley Fool]
▶ Teladoc Adds Peter Nieves as Chief Revenue Officer   [Mar-13-17 09:15AM  Business Wire]
▶ [$$] Smart Thermometer Startup Kinsa Collects Series B   [Mar-08-17 07:30AM  at The Wall Street Journal]
▶ Teladoc reports 4Q loss   [04:22PM  AP]
▶ Here's Why Teladoc Soared Nearly 14% Higher This Morning   [Jan-19-17 11:50AM  at Motley Fool]
▶ Teladoc Announces Pricing of Sale of Shares of Common Stock   [Jan-18-17 06:25PM  Business Wire]
▶ Teladoc Announces Proposed Sale of Shares of Common Stock   [Jan-17-17 04:01PM  Business Wire]
▶ Analyte Health and Teladoc Announce Partnership   [Jan-09-17 12:34PM  Business Wire]
Stock chart of TDOC Financial statements of TDOC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.